Cramer: Apple Is Th...
Covidien PLC (COV: NYSE)
$50.67 -1.11 | -2.14%
06/01/12 - 04:01 PM ET
Company Cash Flow
| Sep 2011 | Sep 2010 | Sep 2009 | Sep 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 1.87B | 1.63B | 907.00M | 1.36B |
| Operating Gains/Losses | -11.00M | 25.00M | -148.00M | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -9.00M | -7.00M | 71.00M | -138.00M |
| (Increase) Decrease in Inventories | -203.00M | -49.00M | -53.00M | -190.00M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -13.00M | 68.00M | -68.00M | 72.00M |
| (Decrease) Increase In Other Current Liabilities | -354.00M | 112.00M | 616.00M | -1.05B |
| (Increase) Decrease In Other Working Capital | 28.00M | -27.00M | -165.00M | 33.00M |
| Other Non-Cash Items | 177.00M | 104.00M | 348.00M | 25.00M |
| Net Cash From Continuing Operations | 2.18B | 2.18B | 1.88B | 509.00M |
| Net Cash From Discontinued Operations | 0.00 | 46.00M | 0.00 | 151.00M |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 2.18B | 2.23B | 1.88B | 660.00M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -473.00M | -471.00M | -468.00M | -409.00M |
| Acquisitions | -13.00M | -3.01B | -602.00M | 106.00M |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | -11.00M | 234.00M | -5.00M | 1.30B |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -480.00M | -3.21B | -1.03B | 966.00M |
| Issuance of Debt | 0.00 | 1.49B | 0.00 | 2.90B |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 176.00M | 107.00M | 19.00M | 157.00M |
| Repayment of Long-Term Debt | -258.00M | -88.00M | -39.00M | -4.01B |
| Repurchase of Capital Stock | -955.00M | -331.00M | -232.00M | 0.00 |
| Payment of Cash Dividends | -396.00M | -360.00M | -322.00M | -320.00M |
| Other Financing Charges, Net | -338.00M | 243.00M | -1.00M | -11.00M |
| Net Cash From Financing Activities | -1.77B | 1.06B | -575.00M | -1.28B |
| Effect of Exchange Rate Changes | 7.00M | 13.00M | -14.00M | -7.00M |
| Net Change in Cash & Cash Equivalents | -62.00M | 98.00M | 259.00M | 336.00M |
Portfolios with COV
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 16
- ProJohn Paulson
- ContributorTop-Yielding Health Service...
- UserGFNN Stockdiagnostics 4
- ProKaren Finerman - Metropolit...
- ProPrivate Capital Management
- ContributorHealth Care Stocks Bought a...
- ContributorJohn Paulson's 10 Best New ...
- Contributor8 Health Care Stocks to Buy
- ProTPG-Axon Capital
Latest COV Headlines from TheStreet
- Cramer's 'Mad Money' Recap: Europe's Problems a Global Problem 06.01.12 | 07:06 pm
- Covidien PLC (COV): Today's Featured Health Services Winner 05.24.12 | 05:05 pm
- Covidien PLC (COV): Today's Featured Health Services Winner 05.08.12 | 04:05 pm
- Covidien PLC (COV): Today's Featured Health Services Winner 05.01.12 | 05:05 pm
- Covidien's CEO Discusses Q2 2012 Results - Earnings Call Transcript 04.27.12 | 01:04 pm
- Covidien Stock To Go Ex-dividend Monday (COV) 03.30.12 | 09:03 am
- 8 Ex-Dividend Stocks With Buy Ratings 03.30.12 | 05:03 am
- Tyco Investors Not Free From Kozlowski 03.29.12 | 09:03 am
- Pfizer Needs to Think About Splitting: Goldman 03.27.12 | 03:03 pm
- Cramer's 'Mad Money' Recap: Balancing Act (Final) 02.08.12 | 07:02 pm
Press Releases for COV
- Endo GIA(TM) Radial Reload With Tri-Staple(TM) Technology (Photo: Business Wire) - Business Wire 05.31.12 | 06:05 pm
- Covidien To Present At Goldman Sachs Conference - Business Wire 05.31.12 | 07:05 am
- Covalon Provides Corporate Update And Second Quarter Fiscal 2012 Financial Results - PR Newswire 05.28.12 | 08:05 am
- Covidien Announces Pricing Of $1.250 Billion Senior Notes Offering - Business Wire 05.22.12 | 04:05 pm
- Covidien Announces Senior Notes Offering And Redemption Of 5.450% Senior Notes Due October 2012 - Business Wire 05.22.12 | 09:05 am
- Covidien Appoints Gregory S. Andrulonis Vice President And Treasurer - Business Wire 05.21.12 | 04:05 pm
- Covalon To Unveil Its SilverCoat⢠Antimicrobial Silicone Foley Catheter At The 2012 American Urological Association Annual Meeting In Atlanta - PR Newswire 05.18.12 | 01:05 pm
- Covidien Completes Acquisition Of SuperDimension, Ltd. - Business Wire 05.15.12 | 04:05 pm
- Covalon Announces Major Milestone: Achieves FDA Approval For IV Clear⢠- A Breakthrough Antimicrobial Silicone Adhesive Film Dressing For Securing Vascular Access Medical Devices - PR Newswire 05.15.12 | 08:05 am
- Covidien, A Leading Global Provider Of Healthcare Products, Will Unveil Its New OneShot™ Renal Denervation System At The EuroPCR Congress In Paris, France, On May 16, 2012. (Photo: Business Wire) - Business Wire 05.08.12 | 07:05 am
Partner Headlines for COV
- COV Launches Endo GIA Radial Reload - Analyst Blog - Zacks 06.01.12 | 05:06 pm
- Covidien Prices Senior Notes - Analyst Blog - Zacks 05.25.12 | 04:05 pm
- John Paulson Buys Almost 10 Percent of Caesar's, Buffett's Viacom and NOV, COV, ABVT, TNB - GuruFocus 05.17.12 | 04:05 pm
- John Paulson Buys Almost 10 Percent of Caesar's, Buffett's Viacom - GuruFocus 05.17.12 | 04:05 pm
- The Zacks Analyst Blog Highlights: Covidien, General Electrical, Becton, Dickinson and Company, Johnson and Johnson and CR Bard - Press Releases - Zacks 05.14.12 | 09:05 am
- UPDATE: Deutsche Bank Raises PT to $62 on Covidien; FQ2 Beats Expectations - Benzinga 05.01.12 | 09:05 am
- Covidien to Acquire Oridion Systems - Analyst Blog - Zacks 04.13.12 | 04:04 pm
- Covidien Takes Over superDimension - Analyst Blog - Zacks 04.03.12 | 09:04 am
- Covidien Announces Study Results Demonstrating Benefits of Minimally Invasive Surgery over Traditional Open Procedures - Benzinga 03.12.12 | 04:03 pm
- The Zacks Analyst Blog Highlights: Applied Materials, Covidien, Johnson & Johnson, Becton Dickinson and C.R. Bard - Press Releases - Zacks 03.08.12 | 09:03 am





